We work in the area of mental health for one of our clients, which means we can list off the names of prominent thinkers in the field, the main medical meetings, and the DSM-V diagnostic criteria for depression. But, what can be harder to talk about is when someone in our close-knit team is affected by poor mental health. Read more
Patient-Pharma interactions are vital for drug development, but are often seen in a negative light. There will always be sceptics; those who think pharma companies have cynical intentions when approaching patients, and conversely, those who feel some patients advocate for the wrong motives. However, in recent years patient advocacy has become a pivotal aspect of the drug development process, where pharma companies have increasingly sought the unique insight that patients can offer.
So can there be a healthy and mutually beneficial relationship between patients and pharmaceutical companies? Read more